Director/PDMR Shareholding

RNS Number : 5282C

GlaxoSmithKline PLC

19 January 2015

 

GlaxoSmithKline plc

 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors, Persons Discharging Managerial Responsibilities (PDMR) and Connected Persons on 16 January 2015 of the following increases in their notional interests in Ordinary Shares at a price of 1427.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $43.19 per ADS following the notional re-investment of the dividend paid to shareholders on 8 January 2015.

Director/PDMR	Ordinary Shares	ADSs
Sir Andrew Witty	18,634.726
Dr M M Slaoui		5,838.447
Mr S Dingemans	7,826.922
Mr R G Connor	2,559.691
Mrs D P Connelly		2,427.946
Mr N Hirons		314.028
Mr S A Hussain	6,349.257
Mr W C Louv		1,712.688
Mr D S Redfern	2,695.290
Ms C Thomas	3,719.918
Mr P C Thomson	1,814.523
Mr D E Troy		3,469.890
Dr P J T Vallance	7,749.851
Ms E Walmsley	4,505.102
Mrs V A Whyte	515.784

Connected Person	Ordinary Shares	ADSs
Dr K Slaoui (connected person to Dr M M Slaoui)		88.247
Mrs K Thomson (connected person to Mr P C Thomson)	84.998

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

V A Whyte

Company Secretary

19 January 2015

 

END

 

 

RDSXKLFFEFFLBBQ